1 year return (CAGR)
1698.76%
Quince Therapeutics, Inc. Exchange (NASDAQ, USD)
QNCX
28.84
-1.35 (-4.47%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
182.10%
5 year return (CAGR)
-21.23%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
29.45M
Price/Sales
-
Ent value
-71.02M
Price/Book
0.27
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
44.79%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 30.00 |
| Daily high | 30.00 |
| Daily low | 28.31 |
| Daily Volume | 4K |
| All-time high | 120.21 |
| 1y analyst estimate | 77.20 |
| Beta | 1.31 |
| EPS (TTM) | -15.08 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| QNCX | S&P500 | |
| Current price drop from All-time high | -76.00% | -2.63% |
| Highest price drop | -99.89% | -56.47% |
| Date of highest drop | 9 Feb 2026 | 9 Mar 2009 |
| Avg drop from high | -76.10% | -10.69% |
| Avg time to new high | 80 days | 12 days |
| Max time to new high | 1277 days | 1805 days |
News
